Single-Cut Gene Editing Therapy for Duchenne Muscular Dystrophy via a Single AAV Vector

被引：0
|
作者：
Li, Guoling [1 ]
Lin, Jiajia [2 ]
Li, Haisen [1 ]
Jin, Ming [2 ]
Li, Zhifang [3 ]
Shi, Linyu [1 ]
Wang, Ning [2 ]
Chen, Wanjin [2 ]
Yang, Hui [1 ,4 ]
机构：
[1] HuidaGene Therapeut Co Ltd, Shanghai, Peoples R China
[2] Fujian Med Univ, Affiliated Hosp 1, Dept Neurol, Fuzhou, Peoples R China
[3] Lingang Lab, Shanghai, Peoples R China
[4] Chinese Acad Sci, Ctr Excellence Brain Sci & Intelligence Technol, Shanghai, Peoples R China
来源：
MOLECULAR THERAPY | 2023年 / 31卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
951
引用
收藏
页码：461 / 462
页数：2
相关论文
共 50 条
  • [1] Development of hfCas12Max-Based Single-Cut Gene Editing Therapy for Duchenne Muscular Dystrophy
    Li, Guoling
    Lin, Jiajia
    Jin, Ming
    Li, Zhifang
    Li, Tong
    Wang, Shaoran
    Yao, Xuan
    Luk, Alvin
    Yang, Hui
    Shi, Linyu
    MOLECULAR THERAPY, 2024, 32 (04) : 544 - 544
  • [2] A consolidated AAV system for single-cut CRISPR correction of a common Duchenne muscular dystrophy mutation
    Zhang, Yu
    Nishiyama, Takahiko
    Li, Hui
    Huang, Jian
    Atmanli, Ayhan
    Sanchez-Ortiz, Efrain
    Wang, Zhaoning
    Mireault, Alex A.
    Mammen, Pradeep P. A.
    Bassel-Duby, Rhonda
    Olson, Eric N.
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2021, 22 : 122 - 132
  • [3] Correction of Three Prominent Mutations in Mouse and Human Models of Duchenne Muscular Dystrophy by Single-Cut Genome Editing
    Min, Yi-Li
    Chemello, Francesco
    Li, Hui
    Rodriguez-Caycedo, Cristina
    Sanchez-Ortiz, Efrain
    Mireault, Alex A.
    McAnally, John R.
    Shelton, John M.
    Zhang, Yu
    Bassel-Duby, Rhonda
    Olson, Eric N.
    MOLECULAR THERAPY, 2020, 28 (09) : 2044 - 2055
  • [4] Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy
    Amoasii, Leonela
    Long, Chengzu
    Li, Hui
    Mireault, Alex A.
    Shelton, John M.
    Sanchez-Ortiz, Efrain
    McAnally, John R.
    Bhattacharyya, Samadrita
    Schmidt, Florian
    Grimm, Dirk
    Hauschka, Stephen D.
    Bassel-Duby, Rhonda
    Olson, Eric N.
    SCIENCE TRANSLATIONAL MEDICINE, 2017, 9 (418)
  • [5] COMBINATORIAL GENE THERAPY USING AAV VECTOR TECHNOLOGY TO TREAT DUCHENNE MUSCULAR DYSTROPHY
    Colgan, T. D.
    Murphy, K. T.
    Lynch, G. S.
    Gregorevic, P.
    JOURNAL OF GENE MEDICINE, 2013, 15 (8-9): : 325 - 326
  • [6] CRISPR/Cas9 mediated gene editing of Duchenne muscular dystrophy with a single gene deleted adenoviral vector
    Ehrke-Schulz, E.
    Mouly, V.
    Ehrhardt, A.
    HUMAN GENE THERAPY, 2019, 30 (11) : A161 - A161
  • [7] Gene editing for Duchenne muscular dystrophy
    Hannah Stower
    Nature Medicine, 2018, 24 : 1491 - 1491
  • [8] Gene editing for Duchenne muscular dystrophy
    Stower, Hannah
    NATURE MEDICINE, 2018, 24 (10) : 1491 - 1491
  • [9] Immune Response to AAV Vector Capsid and Assessment of Eligibility for AAV Mediated Gene Therapy for Duchenne Muscular Dystrophy
    Saha, Madhurima
    MOLECULAR THERAPY, 2022, 30 (04) : 76 - 76
  • [10] Adeno-associated virus vector (AAV) microdystrophin gene therapy for Duchenne muscular dystrophy
    Dickson, George
    Le Guiner, Caroline
    Servais, Laurent
    Montus, Marie
    Hogrel, Jean-Yves
    Cherel, Yan
    Carlier, Pierre
    Masurier, Carole
    Adjali, Oumeya
    Barnay-Toutain, Frederic
    Koo, Taeyoung
    Athanasopoulos, Takis
    Malerba, Alberto
    Le Heron, Anita
    Mavilio, Fulivi
    Moullier, Philippe
    Voit, Thomas
    HUMAN GENE THERAPY, 2014, 25 (11) : A27 - A27
12345